EcoDrugPlus

Tryptophan Hydroxylase 1b

Ensembl ID : ENSONIG00000003476
Gene Symbol: TPH1B
1 Cross references
176 Possible Orthologues:

Tubulin Alpha 4a

Ensembl ID : ENSONIG00000036516
Gene Symbol: TUBA4A
3 Cross references
155 Possible Orthologues:

Tubulin Beta Chain

Ensembl ID : ENSONIG00000011492
Gene Symbol: LOC100698256
3 Cross references
184 Possible Orthologues:

Tubulin Beta-2a Chain

Ensembl ID : ENSONIG00000009687
Gene Symbol: LOC100702414
4 Cross references
305 Possible Orthologues:

Tumor Protein P53

Ensembl ID : ENSONIG00000018962
Gene Symbol: TP53
4 Cross references
232 Possible Orthologues:

Type Ii Estrogen Receptor

Ensembl ID : ENSONIG00000005633
Gene Symbol: LOC100534515
4 Cross references
198 Possible Orthologues:

Type-2 Angiotensin Ii Receptor

Ensembl ID : ENSONIG00000034527
Gene Symbol: LOC100702180
3 Cross references
185 Possible Orthologues:

Tyrosinase

Ensembl ID : ENSONIG00000005144
Gene Symbol: TYR
4 Cross references
202 Possible Orthologues:

Tyrosinase

Ensembl ID : ENSONIG00000004725
Gene Symbol: TYR
4 Cross references
198 Possible Orthologues:

Tyrosine Hydroxylase

Ensembl ID : ENSONIG00000014492
Gene Symbol: TH
4 Cross references
187 Possible Orthologues:

Tyrosine Kinase 2

Ensembl ID : ENSONIG00000001561
Gene Symbol: TYK2
3 Cross references
195 Possible Orthologues:

Tyrosine Kinase With Immunoglobulin Like And Egf Like Domains 1

Ensembl ID : ENSONIG00000008859
Gene Symbol: TIE1
4 Cross references
205 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).